New HPTLC Chapter Proposed for The International Pharmacopoeia
Recommendation

20/21 January 2027
Ensuring Control of Chromatographs, Integration and Results
The World Health Organization (WHO) has published a draft proposal for a new general chapter "1.18 High-Performance Thin-Layer Chromatography" (HPTLC) to be included in The International Pharmacopoeia.
According to the chapter’s introduction, HPTLC is a chromatographic technique "in which variables are controlled within narrow ranges, using a standardized methodology and appropriate equipment, in order to achieve more reproducible results compared to traditional thin-layer chromatography (TLC)."
The chapter includes:
- An introduction to HPTLC principles
- Required equipment and materials
- A step-by-step analytical procedure
- System suitability criteria and documentation standards
- A new reagent specification (saturated MgCl2 solution)
The draft is currently open for public consultation. Comments can be submitted via the WHO PleaseReview™ platform until 09 September 2025.
The proposed chapter is available on the WHO website under “Working documents in public consultation”.
Related GMP News
06.07.2026Revised Annex 19 on Reference and Retention Samples
01.07.2026Several FDA Warning Letters and Untitled Letters on Asbestos Testing of Talc in OTC Drug Products
24.06.2026Analytical Quality Group Developments January through April 2026
17.06.2026BioPhorum Publishes a Roadmap for QC Sample Test Execution
03.06.2026EMA Provides an Outlook on the Product-Specific Bioequivalence Guidelines Expected in 2026
03.06.2026FDA Warning Letter: Missing Method Validation - From a QC Topic to a Market-Access Problem


